The originally licensed biological product against which a biosimilar is compared.
The reference product holds the exclusivity period that determines when biosimilars can enter.
FDA regulatory
FDA regulatory
The originally licensed biological product against which a biosimilar is compared.
The reference product holds the exclusivity period that determines when biosimilars can enter.